Rachel C. Jankowitz

Oncology

3400 Civic Center Boulevard
West Pavilion, 3rd Floor
Philadelphia, PA 19104

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 71 publications

Breast Cancer, Version 4.2026, NCCN Clinical Practice Guidelines In Oncology.

Breast Cancer, Version 4.2026, NCCN Clinical Practice Guidelines In Oncology.

Journal: Journal of the National Comprehensive Cancer Network : JNCCN

Published: July 09, 2026

Quantitative and qualitative patient-reported analysis of misdiagnosis and/or late diagnosis of metastatic lobular cancer.

Quantitative and qualitative patient-reported analysis of misdiagnosis and/or late diagnosis of metastatic lobular cancer.

Journal: medRxiv : the preprint server for health sciences

Published: May 04, 2026

The Pathologic Response Evaluation and Detection in Circulating Tumor-DNA Study: Ultrasensitive Circulating Tumor-DNA Assessment of Breast Cancer Minimal Residual Disease.

The Pathologic Response Evaluation and Detection in Circulating Tumor-DNA Study: Ultrasensitive Circulating Tumor-DNA Assessment of Breast Cancer Minimal Residual Disease.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: March 10, 2026

NCCN Guidelines® Insights: Breast Cancer, Version 5.2025.

NCCN Guidelines® Insights: Breast Cancer, Version 5.2025.

Journal: Journal of the National Comprehensive Cancer Network : JNCCN

Published: November 10, 2025

Clinical challenges and proposed solutions for patients with invasive lobular breast cancer.

Clinical challenges and proposed solutions for patients with invasive lobular breast cancer.

Journal: Annals of oncology : official journal of the European Society for Medical Oncology

Published: November 22, 2024

FGFR4 in endocrine resistance: overexpression and estrogen regulation without direct causative role.

FGFR4 in endocrine resistance: overexpression and estrogen regulation without direct causative role.

Journal: Breast cancer research and treatment

Published: September 07, 2024

Breast Cancer, Version 3.2024, NCCN Clinical Practice Guidelines in Oncology.

Breast Cancer, Version 3.2024, NCCN Clinical Practice Guidelines in Oncology.

Journal: Journal of the National Comprehensive Cancer Network : JNCCN

Published: July 17, 2024

Adjuvant Trastuzumab Emtansine Versus Paclitaxel Plus Trastuzumab for Stage I Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer: 5-Year Results and Correlative Analyses From ATEMPT.

Adjuvant Trastuzumab Emtansine Versus Paclitaxel Plus Trastuzumab for Stage I Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer: 5-Year Results and Correlative Analyses From ATEMPT.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: June 27, 2024

Correction: NSABP FB-10: a phase Ib/II trial evaluating ado-trastuzumab emtansine (T-DM1) with neratinib in women with metastatic HER2-positive breast cancer.

Correction: NSABP FB-10: a phase Ib/II trial evaluating ado-trastuzumab emtansine (T-DM1) with neratinib in women with metastatic HER2-positive breast cancer.

Journal: Breast cancer research : BCR

Published: May 24, 2024

Estrogen regulation and functional role of FGFR4 in estrogen receptor positive breast cancer.

Estrogen regulation and functional role of FGFR4 in estrogen receptor positive breast cancer.

Journal: bioRxiv : the preprint server for biology

Published: April 02, 2024

International survey on invasive lobular breast cancer identifies priority research questions.

International survey on invasive lobular breast cancer identifies priority research questions.

Journal: NPJ breast cancer

Published: January 23, 2024

Erratum: 53 The development of a multi-institutional prospective registry for patients with metastatic invasive lobular carcinoma: identifying new markers of disease progression - CORRIGENDUM.

Erratum: 53 The development of a multi-institutional prospective registry for patients with metastatic invasive lobular carcinoma: identifying new markers of disease progression - CORRIGENDUM.

Journal: Journal of clinical and translational science

Published: October 13, 2023

Showing 1-12 of 71

Last Updated: 09/26/2026